Stock Price Forecast

July 17, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading SQZ Biotechnologies Co chart...

About the Company

spun out of mit, sqz biotechnologies is developing the next generation of cell therapies, using its propriety technology to harness the power of the patient's immune system to combat disease. sqz: empower cells to change lives.

Exchange

NEW YORK STOCK EXCHANGE INC.

Website

sqzbiotech.com

$21M

Total Revenue

53

Employees

$4M

Market Capitalization

-1.32

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SQZ News

SQZ Biotechnologies Co Ordinary Shares SQZB

1d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Sqz Bio (SQZB) Earnings Dates & Reports

1mon ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

SQZ founder’s new startup raises $5 million in pre seed funding

1mon ago, source: The Business Journals

In December, Armon Sharei launched a new startup, Portal Biotechnologies. The startup is essentially developing the next generation of the tech that his former company, SQZ Technologies ...

SQZ Biotechnologies seeks to expand the universe of cell therapies

2y ago, source: Nature

These cell therapies can also be costly and time-consuming to produce. SQZ Biotechnologies has taken a unique approach to overcome these limitations, creating a novel platform technology that can ...

SQZ, Portal founder Armon Sharei on starting over in biotech

25d ago, source: Yahoo Finance

The company Sharei formed, SQZ Biotechnologies, won a startup competition in 2014, with the magazine Scientific American annointing its technology as one of the year’s top innovations.

Vancouver’s Stemcell continues American biotech buying spree

1mon ago, source: Burnaby Now

Stemcell announced today that shareholders for Massachusetts-based SQZ Biotechnologies SQZ Biotechnologies Company (OTC:SQZB) have approved the sale. Earlier, SQZ reported the proposed sale of its ...

Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC

1mon ago, source: Yahoo Finance

The company was founded by Armon Sharei, Ph.D., founder and former CEO of SQZ Biotechnologies ... Portal is a member of the Bayer Co.Lab, a cell and gene therapy accelerator co-located with ...

SD Biotechnologies Co Ltd

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Thai Kyowa Biotechnologies Co., Ltd. Hotels

1mon ago, source: Skyscanner

Finding cheap hotels near Thai Kyowa Biotechnologies Co., Ltd. We price check hundreds of hotel brands and booking sites, so you don't have to search each one individually. Then we sort by price, ...

CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023

15d ago, source: Hosted on MSN

CollPlant Biotechnologies (NASDAQ:CLGN) just reported results for the fourth quarter of 2023. CollPlant Biotechnologies reported earnings per share of -35 cents. This was below the analyst ...

Sqz Biotechnologies Co (SQZB)

1mon ago, source: Investing

Sqz Bio will announce its quarterly financial results in 14 days. Traders should take this into account as the share price often fluctuates around this time period.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...